AstraZeneca PLC
F:ZEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
F:ZEG
|
UK |
|
Amgen Inc
NASDAQ:AMGN
|
US |
|
PepsiCo Inc
NASDAQ:PEP
|
US |
|
P
|
Paychex Inc
DUS:PCX
|
US |
|
A
|
ASML Holding NV
DUS:ASME
|
NL |
|
G
|
Games Workshop Group PLC
OTC:GMWKF
|
UK |
|
D
|
Diageo PLC
XMUN:GUI
|
UK |
Wall St Price Targets
ZEG Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for ZEG is 194.01 EUR with a low forecast of 132.39 EUR and a high forecast of 226.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZEG's stock price target?
Price Target
194.01
EUR
According to Wall Street analysts, the average 1-year price target for ZEG is 194.01 EUR with a low forecast of 132.39 EUR and a high forecast of 226.54 EUR.
What is the Revenue forecast for AstraZeneca PLC?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for AstraZeneca PLC?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for AstraZeneca PLC?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 21%.
What is the Pre-Tax Income forecast for AstraZeneca PLC?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.
What is the Net Income forecast for AstraZeneca PLC?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 26%.
